Data-driven to the drug of tomorrow

Opportunities and barriers of AI in a GxP world.

AI use cases in the pharmaceutical and healthcare industries.
The risks and potentials of AI in GxP as well as non-GxP processes.
Project report: supported document analysis for targeted identification of adverse drug reactions.

Subscribe to the Merantix Momentum Newsletter now.

The latest industry news, interviews, technologies and resources.

All articles

First to the Finish: How AI in Market Access Will Determine the Future Market Leaders in the Pharmaceutical Industry

Why the future of market access lies not in more processes, but in intelligent automation.

A Deep Dive into Tabular In-Context Learning

ICL Models vs. Boosting for Tabular Data, Where New Transformer Approaches Excel and Where Traditional ML Methods Still Dominate.

Article

DNA-Encoded Libraries and AI for Compound Identification

An expert interview on the use of DNA-encoded libraries for connection detection.

Article

AI-Driven Compound Optimization in the Large Molecule Space

An expert interview on AI-Driven Compound Optimization in the Large Molecule Space.

Article

Why compliance officers can no longer afford to ignore AI

Compliance teams in Switzerland are faced with a flood of regulations. Find out how AI is easing the burden on banks, insurance companies and law firms - and making compliance smarter.

Data-driven to the drug of tomorrow

AI use cases in the pharmaceutical and healthcare industries.
The risks and potentials of AI in GxP as well as non-GxP processes.
Project report: supported document analysis for targeted identification of adverse drug reactions.